These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15645164)

  • 1. Inflammatory mediators in atherosclerotic vascular disease.
    Zernecke A; Weber C
    Basic Res Cardiol; 2005 Mar; 100(2):93-101. PubMed ID: 15645164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in vascular dysfunction and remodeling.
    Schober A
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1950-9. PubMed ID: 18818421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease.
    Weber C; Schober A; Zernecke A
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):1997-2008. PubMed ID: 15319268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in atherosclerosis: an update.
    Zernecke A; Shagdarsuren E; Weber C
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice.
    Braunersreuther V; Steffens S; Arnaud C; Pelli G; Burger F; Proudfoot A; Mach F
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1090-6. PubMed ID: 18388327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specific role of chemokines in atherosclerosis.
    Braunersreuther V; Mach F; Steffens S
    Thromb Haemost; 2007 May; 97(5):714-21. PubMed ID: 17479181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.
    Xu Q; Wang S; Jiang X; Zhao Y; Gao M; Zhang Y; Wang X; Tano K; Kanehara M; Zhang W; Ishida T
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):624-31. PubMed ID: 17581219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
    Veillard NR; Kwak B; Pelli G; Mulhaupt F; James RW; Proudfoot AE; Mach F
    Circ Res; 2004 Feb; 94(2):253-61. PubMed ID: 14656931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in the vascular inflammatory response of atherosclerosis.
    Zernecke A; Weber C
    Cardiovasc Res; 2010 May; 86(2):192-201. PubMed ID: 20007309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
    Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
    Soria G; Ben-Baruch A
    Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
    Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
    Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines in the pathogenesis of vascular disease.
    Charo IF; Taubman MB
    Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
    Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
    J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
    Noels H; Bernhagen J; Weber C
    Trends Cardiovasc Med; 2009 Apr; 19(3):76-86. PubMed ID: 19679264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells.
    Kodali R; Hajjou M; Berman AB; Bansal MB; Zhang S; Pan JJ; Schecter AD
    Cardiovasc Res; 2006 Feb; 69(3):706-15. PubMed ID: 16343467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and cardiovascular risk.
    Aukrust P; Halvorsen B; Yndestad A; Ueland T; Øie E; Otterdal K; Gullestad L; Damås JK
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1909-19. PubMed ID: 18669888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
    Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
    BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.